ARTICLE | Financial News
Viamet replaces IPO with $60M D round
October 22, 2014 3:53 AM UTC
One day after withdrawing a proposed IPO, Viamet Pharmaceuticals Inc. (Durham, N.C.) closed a $60 million series D round led by new investor Brandon Point Industries Ltd. working with Woodford Investment Management.
The company did not respond to inquiries about whether existing investors participated. They include Novartis Venture Fund; Lilly Ventures; Hatteras Venture Partners; Intersouth Partners; Lurie Holdings; and Astellas Venture Management. ...